Clinical Trial Update: Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial updating primary and booster vaccination with GSK1024850A and prophylactic antipyretic treatment; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Streptococcal

Drugs mentioned

• GSK1024850A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 4 | Status: COMPLETED | Results posted: 2019-01-31